These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 19642125

  • 1. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I, Ulloa E, Colina F, Abradelo M, Jiménez C, Gimeno A, Meneu JC, Lumbreras C, Solís-Herruzo JA, Moreno E.
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [Abstract] [Full Text] [Related]

  • 2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [Abstract] [Full Text] [Related]

  • 3. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C.
    Berenguer M, Palau A, Fernandez A, Benlloch S, Aguilera V, Prieto M, Rayón JM, Berenguer J.
    Liver Transpl; 2006 Jul; 12(7):1067-76. PubMed ID: 16622844
    [Abstract] [Full Text] [Related]

  • 4. Outcomes of acute rejection after interferon therapy in liver transplant recipients.
    Saab S, Kalmaz D, Gajjar NA, Hiatt J, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Goldstein LI, Lassman CR, Busuttil RW.
    Liver Transpl; 2004 Jul; 10(7):859-67. PubMed ID: 15237369
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S.
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.
    Firpi RJ, Zhu H, Morelli G, Abdelmalek MF, Soldevila-Pico C, Machicao VI, Cabrera R, Reed AI, Liu C, Nelson DR.
    Liver Transpl; 2006 Jan; 12(1):51-7. PubMed ID: 16382464
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis C therapy before and after liver transplantation.
    Terrault NA.
    Liver Transpl; 2008 Oct; 14 Suppl 2():S58-66. PubMed ID: 18825697
    [Abstract] [Full Text] [Related]

  • 8. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
    Cescon M, Grazi GL, Cucchetti A, Vetrone G, Ravaioli M, Ercolani G, Morelli MC, Piscaglia F, Tamè M, Pinna AD.
    Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D.
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [Abstract] [Full Text] [Related]

  • 10. Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: biochemical, virological, and histological impact.
    Walter T, Scoazec JY, Guillaud O, Hervieu V, Chevallier P, Boillot O, Dumortier J.
    Liver Transpl; 2009 Jan; 15(1):54-63. PubMed ID: 19109834
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis C.
    Burra P.
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [Abstract] [Full Text] [Related]

  • 12. Relapse response to interferon and ribavirin in liver transplant recipient with hepatitis C recurrence.
    Coccoli P, Cordone G, Bruno M, Parrilli G.
    Transplant Proc; 2005 Dec; 37(10):4406-7. PubMed ID: 16387132
    [Abstract] [Full Text] [Related]

  • 13. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
    Stintzing S, Schmitt C, Ocker M, Ganslmayer M, Zopf S, Gahr S, Hahn EG, Herold C.
    Hepatogastroenterology; 2009 Dec; 56(90):462-5. PubMed ID: 19579621
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports.
    Casanovas T, Argudo A, Peña-Cala MC.
    Transplant Proc; 2011 Dec; 43(6):2233-6. PubMed ID: 21839242
    [Abstract] [Full Text] [Related]

  • 15. Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha.
    Hassan Q, Roche B, Buffet C, Bessede T, Samuel D, Charpentier B, Durrbach A.
    Transpl Int; 2012 Sep; 25(9):941-7. PubMed ID: 22882335
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
    Walter T, Dumortier J, Guillaud O, Hervieu V, Scoazec JY, Boillot O.
    Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
    [Abstract] [Full Text] [Related]

  • 17. Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients with recurrent hepatitis C.
    Barcena R, Oton E, Barreales M, Castillo M, Blesa C.
    Transplant Proc; 2006 Oct; 38(8):2502-4. PubMed ID: 17097981
    [Abstract] [Full Text] [Related]

  • 18. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L, Mazzoni A, Colombatto P, Bindi L, Biancofiore G, Tascini C, Menichetti F, Brunetto MR, Scatena F, Filipponi F.
    Transplantation; 2008 Dec 27; 86(12):1666-71. PubMed ID: 19104402
    [Abstract] [Full Text] [Related]

  • 19. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
    Arjal RR, Burton JR, Villamil F, Rosen HR.
    Aliment Pharmacol Ther; 2007 Jul 15; 26(2):127-40. PubMed ID: 17593060
    [Abstract] [Full Text] [Related]

  • 20. Treating hepatitis C infection in liver transplant recipients.
    Terrault NA, Berenguer M.
    Liver Transpl; 2006 Aug 15; 12(8):1192-204. PubMed ID: 16868944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.